Healthcor Management Initiates Exposure to Oxygen Biotherapeutics, Inc. (OXBT)

Arthur Cohen and Joseph Healey‘s Healthcor Management has added Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) to its equity portfolio. The fund revealed holding 1.5 million shares of the company, the stake being equal to 5.39% of the outstanding stock.

Arthur B Cohen and Joseph Healey

Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT)s is a small cap healthcare company engaged in developing biotechnology products related to oxygen delivery to tissue. Its stock has gained around 24% since the beginning of the year. For the last quarter of 2013, the company reported a net loss of $0.86 per diluted share, narrowing the loss from $1.45 per share reported for the previous quarter. For 2014, analysts expect the company to deliver a net loss of -$0.87 per share.

Aside from Healthcor, another investor, that has started a stake in Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) recently, is Hal Mintz‘ Sabby Management. Sabby reported, earlier this month, holding more than 1.96 million shares of the company, which represent 7.43% of the outstanding stock. Ellington, managed by Mike Vranos, has also added the company to its equity portfolio during the last quarter of 2013, although it holds a less significant stake, which contains just 34,200 shares.

Earlier this year, Healthcor Management, reported boosting its position in another small-cap healthcare company, CareView Communications Inc (OTCBB:CRVW). In two filings, Healthcor disclosed raising its holding to 39.13 million shares, and then to 55.63 million, which represent 28.6% of the outstanding stock.

Healthcare stocks amass the largest portion of Healthcor’s $1.65 billion equity portfolio. The fund holds the largest position in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX): 10.00 million shares, worth $154.6 million. McKesson Corporation (NYSE:MCK) is the next largest holding, which has been raised by 250% over the quarter to 600,000 shares; followed by Cubist Pharmaceuticals Inc (NASDAQ:CBST), in which the fund owns 1.4 million shares.

Disclosure: none

Recommended Reading:

David Einhorn, Greenlight Capital Raise Stake in BioFuel Energy Corp. (BIOF); Send Business Proposal To Board

Wexford Capital Reveals New Position in Famous Dave’s of America, Inc.(DAVE)

Leon Cooperman is Bullish on London-listed Monitise Plc (MONI) and Raises Stake to 10.9%

 

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!